INS and Hepatic fibrosis: Likewise, in smaller trials, GLP-1RAs (mainly liraglutide) have proven to be more efficient than DPP-4i or insulin, showing similar results with SGLT2i regarding liver fat, serum transaminases, and liver fibrosis, even though SGLT2i were found to be superior in decreasing liver fat content in one study and in reducing ALT levels in another [136, 148, 151].